ESR1 and pulmonary arterial hypertension: Increased expression of estrogen receptors has been observed in PASMCs from PAHpatients, with estrogen receptor alpha (ERα) increased in females, whilst estrogenreceptor beta (ERβ) is increased in males.171 This makes blocking estrogen receptors an attractive target to mitigate theeffects of estrogen in the pathogenesis of PAH.